Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman Says He's Changed His Mind on Donald Trump
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
The Independent2d
Key Trump staff ‘furious’ Musk bashed $500 billion AI deal — as president shrugs it off
It comes following the online spat between Musk and OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by the president earlier this week, who described ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
SiliconRepublic5h
Brazil bans Sam Altman’s iris-scanning tech payments
Brazil's data protection watchdog has banned Tools for Humanity from offering payment for iris scanning in the country.
Hosted on MSN20h
Panic after Sam Altman says AI will require 'changes to social contract' and society
OpenAI CEO Sam Altman is under fire for suggesting that artificial intelligence will upend societal norms after President ...
India Today11h
Sam Altman compares Operator launch to ChatGPT: Here is how they are different
OpenAI has recently released its first AI agent, Operator. But how is it different from the ChatGPT platform? Let's find out.